At a glance
ClinicalIndex Comparison RecordN/ACompleted· 15 enrolled
Drug / intervention
iLux 2020 Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Tear Film Innovations iLux Safety Study
In Brief
A clinical study evaluating iLux 2020 System for Meibomian Gland Dysfunction and Evaporative Dry Eye. Completed, enrolled 15 participants across 1 site.
Detailed Summary
The objective of this study was to measure the temperature of the cornea and surrounding eye tissue temperature immediately after heating the eyelids with the iLux device using the protocol treatment profile. Eligible participants attended one treatment visit, with follow-up one day following the procedure.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMeibomian Gland Dysfunction, Evaporative Dry Eye
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
Enrollment StartMay 2016
Primary CompletionMay 2016
Study CompletionMay 2016
First PostedFeb 2017
TodayJul 2026
First PostedFeb 16, 2017
Enrollment StartMay 3, 2016
Primary CompletionMay 17, 2016
Study CompletionMay 18, 2016
TodayJul 2, 2026
Enrollment to primary: 14 daysPosted 9.4 years ago
Interventions
iLux 2020 Systemdevice
Medical device that applies localized heat and pressure therapy to the eyelid in order to express melted meibum from obstructed glands